Companies similar to ARBUTUS BIOPHARMA CORP (ABUS)
Health Care · NASDAQ
ARBUTUS BIOPHARMA CORP (ABUS)'s closest peers include Gilead Sciences (GILD), Merck & Co. (MRK) and VIR BIOTECHNOLOGY INC (VIR). This peer set is drawn from ABUS's enriched company profile and is informational only — not financial advice.
Similar companies
-
Gilead SciencesGILDHealth Care
A diversified biopharmaceutical company pioneering viral disease treatments, cell therapies, and oncology medicines with a portfolio spanning HIV, hepatitis,…
$136.30 (as of 2026-07-16) · market cap $167.2B
-
Merck & Co.MRKHealth Care
Global pharmaceutical and vaccine leader with oncology, infectious disease, and animal health franchises, anchored by blockbuster immunotherapy Keytruda.
$127.63 (as of 2026-07-16) · market cap $311.9B
-
VIR BIOTECHNOLOGY INCVIRHealth Care
Vir Biotechnology develops novel immunology-driven therapeutics targeting infectious diseases and cancer using proprietary T-cell engagement and masking…
$9.40 (as of 2026-07-16) · market cap $1.6B
Not quite? Describe exactly what you want →
Peers are drawn from ABUS's enriched profile (the same similarity signal the chat uses for "companies like ABUS"). See the full profile: ARBUTUS BIOPHARMA CORP (ABUS).
Last updated 2026-07-16.
Informational only — NOT financial advice. Company data is sourced from SEC EDGAR + Finnhub and shown with its as-of date.